Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Noemi Garcia-Romero"'
Autor:
María Peris-Celda, Josefa Carrión-Navarro, Irina Palacín-Aliana, Pilar Sánchez-Gómez, Ricardo Prat Acín, Noemi Garcia-Romero, Angel Ayuso-Sacido
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Gliomas are the most common brain tumors, which present poor prognosis, due, in part, to tumor cell migration and infiltration into distant brain areas. However, the underlying mechanisms causing such effects are unknown. Hedgehog (HH)–Gli axis is
Externí odkaz:
https://doaj.org/article/c88a69be282341aaa8dd05e20172869e
Autor:
Gorjana Rackov, Noemi Garcia-Romero, Susana Esteban-Rubio, Josefa Carrión-Navarro, Cristobal Belda-Iniesta, Angel Ayuso-Sacido
Publikováno v:
Frontiers in Physiology, Vol 9 (2018)
Extracellular vesicles (EVs) — including exosomes, microvesicles and apoptotic bodies — have received much scientific attention last decade as mediators of a newly discovered cell-to-cell communication system, acting at short and long distances.
Externí odkaz:
https://doaj.org/article/a64b877203a24366b59c92b5105a867d
Publikováno v:
DDFV. Repositorio Institucional de la Universidad Francisco de Vitoria
instname
instname
Glioblastoma (GBM) is the most invasive and deadliest brain cancer in adults. Its inherent heterogeneity has been designated as the main cause of treatment failure. Thus, a deeper understanding of the diversity that shapes GBM pathobiology is of utmo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6301f9832c222697bc0652f789d4c458
https://doi.org/10.1016/j.canlet.2021.12.008
https://doi.org/10.1016/j.canlet.2021.12.008
Autor:
Tomasz Pienkowski, Tomasz Kowalczyk, Noemi Garcia-Romero, Angel Ayuso-Sacido, Michal Ciborowski
Publikováno v:
DDFV. Repositorio Institucional de la Universidad Francisco de Vitoria
instname
instname
The diagnosis of glioma is mainly based on imaging methods that do not distinguish between stage and subtype prior to histopathological analysis. Patients with gliomas are generally diagnosed in the symptomatic stage of the disease. Additionally, hea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a238c9c3e36ef00be65418c8c88870bf
https://pubmed.ncbi.nlm.nih.gov/35304294
https://pubmed.ncbi.nlm.nih.gov/35304294
Autor:
José I. Erices, Ignacio Niechi, Atenea Uribe-Ojeda, María de los Ángeles Toro, Noemí García-Romero, Josefa Carrión-Navarro, Álvaro Monago-Sánchez, Ángel Ayuso-Sacido, Rody San Martin, Claudia Quezada-Monrás
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Glioblastoma (GBM) is the most common and deadly malignant brain tumor, with a median survival of 15 to 17 months for a patient. GBM contains a cellular subpopulation known as GBM stem-like cells (GSCs) that persist in hypoxic niches and are capable
Externí odkaz:
https://doaj.org/article/a4997a619ad3488384a3bdfbb2d5d6f6
Autor:
Tomás Duraj, Josefa Carrión-Navarro, Thomas N. Seyfried, Noemí García-Romero, Angel Ayuso-Sacido
Publikováno v:
Molecular Metabolism, Vol 54, Iss , Pp 101389- (2021)
Background: Aberrant metabolism is recognized as a hallmark of cancer, a pillar necessary for cellular proliferation. Regarding bioenergetics (ATP generation), most cancers display a preference not only toward aerobic glycolysis (“Warburg effect”
Externí odkaz:
https://doaj.org/article/1cc69d1a8e794332a08eaed4cf704f72
Autor:
Irina Palacín-Aliana, Noemí García-Romero, Adrià Asensi-Puig, Josefa Carrión-Navarro, Víctor González-Rumayor, Ángel Ayuso-Sacido
Publikováno v:
Biomedicines, Vol 9, Iss 8, p 906 (2021)
Cancer is one of the leading causes of death worldwide and remains a major public health challenge. The introduction of more sensitive and powerful technologies has permitted the appearance of new tumor-specific molecular aberrations with a significa
Externí odkaz:
https://doaj.org/article/5becb84bfb6646afaf1d743a0af06c37
Autor:
Tomás Duraj, Noemí García-Romero, Josefa Carrión-Navarro, Rodrigo Madurga, Ana Ortiz de Mendivil, Ricardo Prat-Acin, Lina Garcia-Cañamaque, Angel Ayuso-Sacido
Publikováno v:
Cells, Vol 10, Iss 2, p 202 (2021)
Glioblastoma (GBM) is the most aggressive primary brain tumor, with a median survival at diagnosis of 16–20 months. Metabolism represents a new attractive therapeutic target; however, due to high intratumoral heterogeneity, the application of metab
Externí odkaz:
https://doaj.org/article/2bb7bb78260443c2bd111197547134be
Autor:
Sergio Rius-Rocabert, Noemí García-Romero, Antonia García, Angel Ayuso-Sacido, Estanislao Nistal-Villan
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 20, p 7604 (2020)
Glioma tumors are one of the most devastating cancer types. Glioblastoma is the most advanced stage with the worst prognosis. Current therapies are still unable to provide an effective cure. Recent advances in oncolytic immunotherapy have generated g
Externí odkaz:
https://doaj.org/article/94d5cf1e19c64593944f4afc90b6c547
Autor:
Noemi García-Romero, Irina Palacín-Aliana, Susana Esteban-Rubio, Rodrigo Madurga, Sergio Rius-Rocabert, Josefa Carrión-Navarro, Jesús Presa, Sara Cuadrado-Castano, Pilar Sánchez-Gómez, Adolfo García-Sastre, Estanislao Nistal-Villan, Angel Ayuso-Sacido
Publikováno v:
Cells, Vol 9, Iss 6, p 1405 (2020)
Glioblastoma (GBM) is the most aggressive and frequent primary brain tumor in adults with a median overall survival of 15 months. Tumor recurrence and poor prognosis are related to cancer stem cells (CSCs), which drive resistance to therapies. A comm
Externí odkaz:
https://doaj.org/article/e3d420882c5546d082592988770cfb01